Fast and cost-effective screening for SARS-CoV-2 variants in a routine diagnostic setting

Jürgen Durner, Siegfried Burggraf, Ludwig Czibere, Arman Tehrani, David C. Watts, Marc Becker

Research output: Contribution to journalArticlepeer-review

44 Downloads (Pure)

Abstract

Objective: The aim is to recommend a fast and cost-effective screening procedure for UK/SA SARS-CoV-2 variants in a routine diagnostic setting.
Methods: A rapid procedure using qPCR is described to provide clinicians with information about the two currently most prevalent variants (B1.1.7 and B1.351) that harbour receptor binding domain mutation N501Y. The N501Y specific assay only delivers an amplification
signal if the Y501 variant is present.
Results: 436 samples initially screened positive for SARS-CoV-2 were randomly selected. Only one of these samples showed a fluorescence signal increase indicative for the Y501 variant. The remaining 435 samples had a melting peak at 54 °C indicating the N501 wildtype.
Significance: The screening of a broad population base can still be performed with the established test system. In case of a positive test for SARS-CoV-2 and corresponding clinical and anamnestic indications, a second qPCR for the mutation N501Y can follow and deliver
the result to public health authorities and to the treating physician within a few hours.
Original languageEnglish
Pages (from-to)e95-e97
JournalDental Materials
Volume37
Issue number3
DOIs
Publication statusPublished - 29 Jan 2021

Fingerprint

Dive into the research topics of 'Fast and cost-effective screening for SARS-CoV-2 variants in a routine diagnostic setting'. Together they form a unique fingerprint.

Cite this